| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 7 | |
| #2 | United States | 6 | |
| #3 | Canada | 4 | |
| #4 | China | 4 | |
| #5 | Australia | 2 | |
| #6 | Republic of Korea | 2 | |
| #7 | WIPO (World Intellectual Property Organization) | 2 | |
| #8 | Japan | 1 | |
| #9 | Russian Federation | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Measurement | |
| #4 | Medical technology |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Therapeutic chemical compounds | |
| #3 | Medical preparations | |
| #4 | Analysing materials | |
| #5 | Electrotherapy |
| # | Name | Total Patents |
|---|---|---|
| #1 | Le Doussal Jean-Marc | 23 |
| #2 | Dorvillius Mylene | 19 |
| #3 | Terme Mickael | 16 |
| #4 | Cochonneau Denis | 12 |
| #5 | Assouline Brigitte | 12 |
| #6 | Terme Mickaël | 11 |
| #7 | Birkle Stephane | 7 |
| #8 | Fleurence Julien | 6 |
| #9 | Birkle Stéphane | 5 |
| #10 | Le Doussal Jean Marc | 4 |
| Publication | Filing date | Title |
|---|---|---|
| US2019023808A1 | Targeting o-acetylated gd2 ganglioside as a new therapeutic and diagnostic strategy for Cancer Stem Cells cancer | |
| EP3329937A1 | Use of antibody against o-acetylated gd2 ganglioside to improve the therapeutic potential of drugs | |
| EP3269739A1 | Humanized antibody against o-acetylated gd2 ganglioside (oacgd2) | |
| CN106414494A | Human IgG1 derived antibody with pro-apoptotic activity | |
| KR20160003190A | Targeting o-acetylated gd2 ganglioside as a new therapeutic and diagnostic strategy for cancer stem cells cancer |